AdaptiveStim Objectifying Subjective Pain Questionnaires
EMINENT
1 other identifier
interventional
39
1 country
2
Brief Summary
This is a prospective, multi-center, correlation study in which the investigators aim to explore the relationship between subjective pain questionnaires and the AdaptiveStim accelerometer output.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2016
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2016
CompletedFirst Submitted
Initial submission to the registry
November 22, 2016
CompletedFirst Posted
Study publicly available on registry
November 28, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2017
CompletedJuly 13, 2017
July 1, 2017
6 months
November 22, 2016
July 12, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
AdaptiveStim output
The Implantable Pulse Generator contains a processor and accelerometer to record objective information about 7 functional positions.
The change between baseline (T1) and the second assessment 7 days later (T1+7days)
Disability
Disability will be measured using the Oswestry Disability Index (ODI) questionnaire
Disability will be measured at the second assessment namely 7 days after the first assessment
Secondary Outcomes (3)
Numeric Rating Scale (NRS) pain diary
Three times every day (morning, afternoon and evening), during 7 days (from baseline assessment (T1) to second assessment (T1+7days))
Objective sleep quality will be measured using the Actiwatch spectrum plus (Respironics).
Three times every day (morning, afternoon and evening), during 7 days (from baseline assessment (T1) to second assessment (T1+7days))
Subjective sleep quality
Disability will be measured at the second assessment namely 7 days after the first assessment
Study Arms (1)
spinal cord stimulation(RestoreSensor)
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- FBSS patients treated with SCS (IPG = RestoreSensor) who achieved a steady state (steady state is considered when the parameters didn't changed for at least one month)
- Age \> 18 years
You may not qualify if:
- Patients with Parkinson's disease
- Patients immobilised due to limb/pelvis/costal fractures
- Stroke patients with MRS\>3
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Moens Maartenlead
- Medtroniccollaborator
Study Sites (2)
AZ Nikolaas
Sint-Niklaas, Oost-Vlaanderen, 9100, Belgium
UZ Brussel
Brussels, Vlaams Brabant, 1090, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Prof. dr.
Study Record Dates
First Submitted
November 22, 2016
First Posted
November 28, 2016
Study Start
November 1, 2016
Primary Completion
May 1, 2017
Study Completion
June 1, 2017
Last Updated
July 13, 2017
Record last verified: 2017-07